Pazopanib in rare histologies of metastatic soft tissue sarcoma
Pazopanib in rare histologies of metastatic soft tissue sarcoma
About this item
Full title
Author / Creator
Publisher
England: Cancer Intelligence
Journal title
Language
English
Formats
Publication information
Publisher
England: Cancer Intelligence
Subjects
More information
Scope and Contents
Contents
Uncommon histopathological subtypes account for less than 5% cases of soft tissue sarcoma (STS) and unclassified STSs comprise another 16%, these are often chemotherapy-resistant, with a dismal outcome in unresectable/metastatic disease. Prospective studies on the use of pazopanib in this cohort of patients are lacking in the literature. Here, we d...
Alternative Titles
Full title
Pazopanib in rare histologies of metastatic soft tissue sarcoma
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8580588
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8580588
Other Identifiers
ISSN
1754-6605
E-ISSN
1754-6605
DOI
10.3332/ecancer.2021.1281
